Anika Therapeutics Inc.
0.0 %
-26.36 %
Yet to be announced
Company Overview
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. The company focuses on developing, manufacturing, and commercializing innovative therapeutic products for pain management, tissue regeneration, and wound healing. Their portfolio includes hyaluronic acid-based solutions, regenerative therapies, and joint preservation treatments.
Revenue Sources
Based on review of Anika Therapeutics' business model and revenue sources, the company primarily generates revenue from medical devices and therapeutic products for orthopedic care. These products and services are halal as they provide legitimate medical benefits and do not involve prohibited substances or activities.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $38.75m | $66.77m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $41.92m | $41.76m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $40.52m | $45.59m | - | - | 0.00% | 0.00% |
| Dec. 31, 2023 | $42.97m | $106.75m | - | - | 0.00% | 0.00% |
Analysis of the financial statements for the past four quarters shows zero interest income and zero interest expense. The company operates without significant reliance on interest-based financing or income.
Operational Ethics
After reviewing available company documents and public information, there is no evidence of significant ongoing associations with entities involved in human rights violations such as the state of Israel or the Chinese Communist Party.
Login to join the discussion